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I NTRO D U C TIO N
Surgical myectomy is an established treatment in symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM) refractory to medical treatment. (1, 2) In nonsurgical patients, alcohol septal ablation is used as an alternative to surgical myectomy, and has been shown to effectively reduce left ventricular outflow tract (LVOT) obstruction and relieve symptoms. However, this treatment is limited by a high incidence of complete heart block, which requires permanent pacing. More recently, septal reduction by coil embolisation in order to avoid alcohol toxicity has been proposed as an alternative.
CA S E R EPO RT
A 34-year-old Chinese male patient was referred to our hospital with a history of presyncope and increasing dyspnoea on exertion. He was diagnosed with HOCM three years ago at another institution and treated with atenolol 25 mg twice daily (bd) and a prophylactic implantation of an automatic internal cardiac defibrillator. At follow-up 18 months later, the patient continued to do well with no reported symptoms of dyspnoea or presyncope.
Repeat echocardiography showed a small reduction in septal thickness (2.56 cm), with a peak LVOT gradient of 24 mmHg at rest and 36 mmHg during Valsalva manoeuvre (Fig. 5) . 
Recently, in order to define the extent of myocardium that is at risk, so as to identify patients who are more likely to develop complications following the procedure, the usage of intraprocedural contrast echocardiography has been proposed.
Coil embolisation emerged as an alternative in our case, as our patient refused surgery and we wanted to avoid potential serious complications associated with alcohol ablation such as complete heart block and unintended spillage of alcohol into the left anterior descending artery, which could lead to severe complications. Coil embolisation technique is used in many settings, including the occlusion of small vessels such as intracranial aneurysms and patent ductus arteriosus, and during coronary interventions in cases of coronary perforation. The aim of performing coil embolisation in HOCM is to cause septal ischaemia and secondary necrosis. Durand et al (7) described twenty patients with HOCM who had undergone septal reduction using coil embolisation; occlusion of the septal branches was successful in all patients, with no incidence of complete heart block or ventricular tachycardia at four months follow-up. However, one patient developed ventricular septal defect and died 19 days after the procedure.
At six months follow-up, all the remaining patients reported However, the patient has refused to undergo a repeat study thus far. To the best of our knowledge, this is the first local case of a patient with HOCM treated by nonsurgical septal reduction in Singapore.
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